BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharma Journalist - ECPv6.16.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Pharma Journalist
X-ORIGINAL-URL:https://www.pharmajournalist.com
X-WR-CALDESC:Events for Pharma Journalist
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Asia/Kolkata
BEGIN:STANDARD
TZOFFSETFROM:+0530
TZOFFSETTO:+0530
TZNAME:IST
DTSTART:20180101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190225
DTEND;VALUE=DATE:20190227
DTSTAMP:20260514T223735
CREATED:20181206T111248Z
LAST-MODIFIED:20181206T111248Z
UID:18683-1551052800-1551225599@www.pharmajournalist.com
SUMMARY:3rd European Clinical Quality Oversight Forum
DESCRIPTION:The European Clinical Quality Oversight Forum in London is the ONLY European event dedicated to risk-based approaches for selecting\, managing and monitoring clinical vendors and sites. This interactive event focuses on ensuring trial integrity by effectively assessing\, optimising and managing the quality of clinical vendors and sites. \n \nTo learn more about this event\, visit https://goo.gl/uPWwum
URL:https://www.pharmajournalist.com/event/3rd-european-clinical-quality-oversight-forum/
LOCATION:Hilton London Canary Wharf\, South Quay\, Marsh Wall\, London\, E14 9SH\, United Kingdom
ORGANIZER;CN="ExL Events":MAILTO:contact@exlevents.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190225
DTEND;VALUE=DATE:20190228
DTSTAMP:20260514T223735
CREATED:20190103T104014Z
LAST-MODIFIED:20190103T104149Z
UID:18924-1551052800-1551311999@www.pharmajournalist.com
SUMMARY:CAR-TCR Summit Europe
DESCRIPTION:The industry-focused CAR-TCR Summit Europe is dedicated to developing\, translating and delivering next generation CAR and TCR therapies for patients in Europe. \n \nJoin over 250 of Europe’s leading drug developers to learn about never-before-seen clinical updates and novel technology to improve solid tumour targeting\, advance allogeneic therapy development and automate manufacturing processes in order to create a targeted\, efficacious and commercially viable cancer therapy. \nFor more information\, visit www.cartcr-europe.com
URL:https://www.pharmajournalist.com/event/car-tcr-summit-europe/
LOCATION:Novotel London West\, 1 Shortlands\, Hammersmith\, London\, W6 8DR\, United Kingdom
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190225
DTEND;VALUE=DATE:20190227
DTSTAMP:20260514T223735
CREATED:20190108T100940Z
LAST-MODIFIED:20190108T100940Z
UID:18951-1551052800-1551225599@www.pharmajournalist.com
SUMMARY:Global NASH Congress
DESCRIPTION:Attracting experts working in all areas of nonalcoholic steatohepatitis\, the Global NASH Congress will examine the latest research and development in pathogenesis\, diagnosis\, and treatment of the disease. An increasing number of people are being diagnosed with the nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) each year\, and the primary method of treatment is weight loss. With no approved medicines on the market\, the drug development race is intensifying. The pathogenesis of NASH is still not fully understood\, and definitive diagnostic methods are invasive\, so development has been slow. There are\, however\, promising developments in research that will hopefully bolster drug development and other methods of treatment. Examples of such developments include improved in vivo liver models\, non-invasive diagnostic biomarkers and a better understanding of the disease’s mechanisms. This year’s congress will focus on these exciting advancements\, as well as on the challenges of preclinical and clinical research in NASH. There will also be a session on business development/regulation and a showcase of the most promising therapeutics in development.
URL:https://www.pharmajournalist.com/event/global-nash-congress/
LOCATION:London\, United Kingdom\, London Heathrow Marriott Hotel\, London\, United Kingdom
ORGANIZER;CN="Global Engage":MAILTO:kieran@globalengage.co.uk
END:VEVENT
END:VCALENDAR